{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:49:26Z","timestamp":1780663766934,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.diagmicrobio.2005.05.002","type":"journal-article","created":{"date-parts":[[2005,8,15]],"date-time":"2005-08-15T11:05:49Z","timestamp":1124103949000},"page":"203-208","source":"Crossref","is-referenced-by-count":83,"title":["Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit"],"prefix":"10.1016","volume":"52","author":[{"given":"Helio S.","family":"Sader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Dowzicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib1","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1128\/AAC.40.9.2226","article-title":"Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection","volume":"40","author":"Bergeron","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/jac\/dkf196","article-title":"Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia","volume":"50","author":"Betriu","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0732-8893(01)00269-3","article-title":"In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant Gram-positive bloodstream infection isolates and strains producing extended-spectrum \u03b2-lactamases","volume":"40","author":"Biedenbach","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/jac\/dkg289","article-title":"In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides","volume":"52","author":"Cercenado","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib5","series-title":"Performance standards for antimicrobial susceptibility testing, 15th informational supplement M100-S15","author":"Clinical and Laboratory Standards Institute","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s100960100455","volume":"20","author":"Fluit","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-5231(05)70143-X","article-title":"Antimicrobial resistance in intensive care units","volume":"20","author":"Fridkin","year":"1999","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3201\/eid0807.010427","article-title":"The Intensive Care Antimicrobial Resistance Epidemiology (CARE) project hospitals. Temporal change sin prevalence of antimicrobial resistance in 23 U.S. hospitals","volume":"8","author":"Fridkin","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ijantimicag.2004.07.007","article-title":"Antimicrobial activity of tigecycline (GAR-936) tested against 3,498 recent isolates of Staphylococcus aureus recovered from nosocomial and community-acquired infections","volume":"24","author":"Fritsche","year":"2004","journal-title":"Intern J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2004.03.002","article-title":"In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and Gram-positive cutaneous infections","volume":"49","author":"Fritsche","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0732-8893(99)00090-5","article-title":"Disk diffusion susceptibility test development for the new glycylcycline. GAR-936","volume":"35","author":"Jones","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijantimicag.2004.11.006","article-title":"Tigecycline: clinical evidence and formulary positioning","volume":"25","author":"Nathwani","year":"2005","journal-title":"Intern J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib13","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-sixth edition. Approved document M7-A6","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib14","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/AAC.46.8.2595-2601.2002","article-title":"In vitro and in vivo activities of tigecycline (GAR-926), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant Gram-positive pathogens","volume":"46","author":"Petersen","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijantimicag.2003.12.019","article-title":"Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001)","volume":"24","author":"Streit","year":"2004","journal-title":"Intern J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib17","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2005.05.002_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003495-200464010-00005","article-title":"The glycylcyclines: a comparative review with the tetracyclines","volume":"64","author":"Zhanel","year":"2004","journal-title":"Drugs"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288930500129X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073288930500129X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T17:48:36Z","timestamp":1552758516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073288930500129X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S073288930500129X"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2005.05.002","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}